SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors weigh strong backlog growth and a newly announced multi-satellite communications contract against concerns over market volatility and sector-wide sentiment. Community discourse is highly polarized, with bulls highlighting the company's expanding project pipeline as a long-term catalyst, while bears argue that recent price action is a trap and point to upcoming mission risks and potential dilution.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is experiencing significant momentum and investor attention as it progresses toward its merger with Agility Robotics, a pure-play humanoid robotics firm backed by strategic heavyweights like NVIDIA, Amazon, and Foxconn. The stock is being buoyed by the broader robotics investment theme and notable institutional stake disclosures, leading community members to draw optimistic parallels to previous successful SPAC transitions in the infrastructure and automation sectors.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as shareholders react to aggressive share dilution and the company's potential exclusion from MSCI indexes. Investors remain deeply divided, with some betting on a long-term Bitcoin treasury play while others express frustration over the stock's divergence from Bitcoin's price action and continued reliance on capital raises.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber shares are experiencing significant downward pressure following the announcement of a $250 million convertible senior note offering, which has sparked immediate concerns regarding shareholder dilution. While some investors remain optimistic about the company's data center expansion and long-term revenue potential, the community is actively debating the company's capital-intensive strategy and the risk of further equity offerings.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is surging after reporting robust Phase 3 trial results for avexitide in post-bariatric hypoglycemia, a milestone that significantly derisks its primary clinical asset. The rally has been further fueled by a $350 million equity offering and positive analyst coverage, leaving short sellers heavily exposed as the community debates the stock's future liquidity and growth potential.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense volatility as market participants fiercely debate the platform's long-term viability and its deep ties to Donald Trump's political brand. The discourse is dominated by polarized community sentiment, with discussions centering on the company's financial performance, potential for dilution, and the broader implications of the current administration's geopolitical policies.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing intense selling pressure as a landmark federal trial begins, with investors concerned over potential multibillion-dollar penalties and long-term business model changes. While the community is deeply divided between those viewing the legal risks as overblown buying opportunities and those concerned that the company's aggressive AI capital expenditure is unsustainable amid mounting regulatory headwinds.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is trending as investor focus intensifies on the strong commercial execution of its lead drug, Ibtrozi, and anticipation for future data readouts on its pipeline, including the glioma drug safusidenib. Community sentiment remains bullish, with many participants citing recent institutional accumulation and optimistic analyst coverage as catalysts for potential long-term upside.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors digest a strong earnings report and raised revenue guidance, fueling optimism for the company's growth trajectory and its blockbuster-potential asset, RECORLEV. The community is focused on the upcoming Phase 3 development of XP-8121, with many discussing the potential for a significant valuation re-rate as the company pivots toward profitability and expands its commercial presence.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is currently experiencing significant downward price volatility following reports of a potential security exploit involving ACLs and active dumping by large whale accounts. While the community remains divided between those panic-selling and those viewing the dip as a generational buying opportunity, discussions are heavily focused on the project's long-term utility, upcoming institutional partnerships, and the viability of its cross-border payment rails.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ManpowerGroup Elects John B. Gibson Jr. to Board of Directors

ManpowerGroup Elects John B. Gibson Jr. to Board of Directors ManpowerGroup Elects John B. Gibson Jr. to Board of Directors PR Newswire MILWAUKEE, Wis., Aug. 11, 2026 MILWAUKEE, Wis., Aug. 11, 2026 /PRNewswire/ -- ManpowerGroup(NYSE: MAN) today announced the appointment of Paychex(Nasdaq: PAYX...

Beat the Market Like Zacks: Aveanna, FactSet, Shopify in Focus

AVAH, FDS and SHOP lead Zacks' recent standouts, with several picks posting strong gains versus the S&P 500.

ADP Earnings Beat as Client Funds Income Powers Stronger FY27 Outlook

ADP's earnings beat, rising client funds income and margin gains support a stronger fiscal 2027 outlook despite PEO pressure.

Is ADP Stock Worth Buying as Growth Improves but Valuation Stays High?

ADP's solid growth, margin gains and cash returns support its appeal, but a 21.5X valuation leaves little room for execution setbacks.

Is NSP Stock Worth Buying After Its Strong Six-Month Rally in 2026?

Insperity's 2026 rally, earnings rebound and 4.4% yield support the case, but stretched valuation, high leverage and weak cash flow limit upside.

How Insperity Is Adapting to AI and a Rapidly Changing PEO Market

NSP is using pricing, HRScale, Workday and AI to revive growth as employee softness, benefits costs and competition pressure margins.

Paychex (PAYX) Shares Cross 4% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Paychex Inc (Symbol: PAYX) were yielding above the 4% mark based on its quarterly dividend (annualized to $4.76), with the stock changing hands as low as $113.69 on the day. Divide...

ADP Q4 Earnings Beat Estimates on Revenue Growth, Margin Gains

ADP beats Q4 earnings and revenue estimates, as broad-based growth, client funds income and productivity lift margins and profits.

S&P Global Q2 Earnings Beat on Ratings & Indices Strength

SPGI's Q2 earnings and revenues top estimates as record Ratings and Indices results lift margins, profit and cash flow.

Why Is Paychex (PAYX) Up 14.4% Since Last Earnings Report?

Paychex (PAYX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Paychex, Inc. engages in the provision of human capital management solutions for payroll, human resources, insurance, and retirement for small and medium-sized businesses. Its solutions include payroll services, hiring services, business insurance, time and attendance, employee benefits, finance and payments, human resources services, and startup services. The company was founded by Blase Thomas Golisano in 1971 and is headquartered in Rochester, NY.

Paychex Inc.

Paychex Stock Gets Price Target Hikes From Morgan Stanley, Citi Post Q3 Earnings — Retail’s Enthusiastic

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PAYXPaychex Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest PAYX News